Rahul Sarugaser
Stock Analyst at Raymond James
(0.02)
# 4,552
Out of 4,944 analysts
10
Total ratings
12.5%
Success rate
-27.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rahul Sarugaser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONCY Oncolytics Biotech | Initiates: Outperform | $3 | $1.02 | +194.12% | 1 | Apr 4, 2024 | |
| QIPT Quipt Home Medical | Downgrades: Market Perform | $10 | $2.03 | +392.61% | 1 | Feb 16, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Market Perform | $100 | $13.26 | +654.15% | 4 | Nov 15, 2023 | |
| PROF Profound Medical | Downgrades: Outperform | n/a | $5.45 | - | 2 | Aug 4, 2023 | |
| VFF Village Farms International | Downgrades: Market Perform | $11 → $2.5 | $2.60 | -3.85% | 2 | Feb 27, 2023 |
Oncolytics Biotech
Apr 4, 2024
Initiates: Outperform
Price Target: $3
Current: $1.02
Upside: +194.12%
Quipt Home Medical
Feb 16, 2024
Downgrades: Market Perform
Price Target: $10
Current: $2.03
Upside: +392.61%
Ginkgo Bioworks Holdings
Nov 15, 2023
Downgrades: Market Perform
Price Target: $100
Current: $13.26
Upside: +654.15%
Profound Medical
Aug 4, 2023
Downgrades: Outperform
Price Target: n/a
Current: $5.45
Upside: -
Village Farms International
Feb 27, 2023
Downgrades: Market Perform
Price Target: $11 → $2.5
Current: $2.60
Upside: -3.85%